0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Alpha Synuclein Market Research Report 2023
Published Date: March 2023
|
Report Code: QYRE-Auto-28J7041
Home | Market Reports | Health| Health Conditions| Neurological Conditions
Global Alpha Synuclein Market Insights Forecast to 2028
BUY CHAPTERS

Global Alpha Synuclein Market Research Report 2023

Code: QYRE-Auto-28J7041
Report
March 2023
Pages:98
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Global Alpha Synuclein Market

The global Alpha Synuclein market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Alpha Synuclein is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Alpha Synuclein is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Alpha Synuclein include AC Immune SA, AFFiRiS AG, BioArctic AB, Biogen Inc, Evotec AG, Genmab A/S, H. Lundbeck A/S, ICB International Inc and MedImmune LLC, etc. in 2022, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Alpha Synuclein, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Alpha Synuclein.
The Alpha Synuclein market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Alpha Synuclein market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Alpha Synuclein manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.

Key Segmentations

By Company

  • AC Immune SA
  • AFFiRiS AG
  • BioArctic AB
  • Biogen Inc
  • Evotec AG
  • Genmab A/S
  • H. Lundbeck A/S
  • ICB International Inc
  • MedImmune LLC
  • Neuropore Therapies Inc
  • nLife Therapeutics SL
  • Prothena Corp Plc
  • QR Pharma Inc
  • reMYND NV

Segment by Type

  • AV-1950R
  • AV-1947D
  • BAN-0805
  • BIIB-054
  • DPC-003
  • Others

Segment by Application

  • Multiple System Atrophy
  • Neurodegenerateive Disease
  • Lewy Body Dementia
  • Others

Consumption by Region

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Russia
  • Asia-Pacific
  • China
  • Japan
  • South Korea
  • India
  • Australia
  • Taiwan
  • Indonesia
  • Thailand
  • Malaysia
  • Philippines
  • Vietnam
  • Latin America
  • Mexico
  • Brazil
  • Argentina
  • Middle East & Africa
  • Turkey
  • Saudi Arabia
  • UAE

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Alpha Synuclein manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Alpha Synuclein in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

Scope of Global Alpha Synuclein Market Report

Report MetricDetails
Report NameGlobal Alpha Synuclein Market
Base Year2022
Forecasted years2023-2029
Forecast unitsUSD
Report coverageRevenue and volume forecast, company share, competitive landscape, growth factors and trends
Geographic regions coveredNorth America, Europe, Asia Pacific, Latin America, Middle East & Africa
1 Alpha Synuclein Market Overview
1.1 Product Overview and Scope of Alpha Synuclein
1.2 Alpha Synuclein Segment by Type
1.2.1 Global Alpha Synuclein Market Value Comparison by Type (2023-2029)
1.2.2 AV-1950R
1.2.3 AV-1947D
1.2.4 BAN-0805
1.2.5 BIIB-054
1.2.6 DPC-003
1.2.7 Others
1.3 Alpha Synuclein Segment by Application
1.3.1 Global Alpha Synuclein Market Value by Application: (2023-2029)
1.3.2 Multiple System Atrophy
1.3.3 Neurodegenerateive Disease
1.3.4 Lewy Body Dementia
1.3.5 Others
1.4 Global Alpha Synuclein Market Size Estimates and Forecasts
1.4.1 Global Alpha Synuclein Revenue 2018-2029
1.4.2 Global Alpha Synuclein Sales 2018-2029
1.4.3 Global Alpha Synuclein Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Alpha Synuclein Market Competition by Manufacturers
2.1 Global Alpha Synuclein Sales Market Share by Manufacturers (2018-2023)
2.2 Global Alpha Synuclein Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Alpha Synuclein Average Price by Manufacturers (2018-2023)
2.4 Global Alpha Synuclein Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Alpha Synuclein, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Alpha Synuclein, Product Type & Application
2.7 Alpha Synuclein Market Competitive Situation and Trends
2.7.1 Alpha Synuclein Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Alpha Synuclein Players Market Share by Revenue
2.7.3 Global Alpha Synuclein Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Alpha Synuclein Retrospective Market Scenario by Region
3.1 Global Alpha Synuclein Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Alpha Synuclein Global Alpha Synuclein Sales by Region: 2018-2029
3.2.1 Global Alpha Synuclein Sales by Region: 2018-2023
3.2.2 Global Alpha Synuclein Sales by Region: 2024-2029
3.3 Global Alpha Synuclein Global Alpha Synuclein Revenue by Region: 2018-2029
3.3.1 Global Alpha Synuclein Revenue by Region: 2018-2023
3.3.2 Global Alpha Synuclein Revenue by Region: 2024-2029
3.4 North America Alpha Synuclein Market Facts & Figures by Country
3.4.1 North America Alpha Synuclein Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Alpha Synuclein Sales by Country (2018-2029)
3.4.3 North America Alpha Synuclein Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Alpha Synuclein Market Facts & Figures by Country
3.5.1 Europe Alpha Synuclein Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Alpha Synuclein Sales by Country (2018-2029)
3.5.3 Europe Alpha Synuclein Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Alpha Synuclein Market Facts & Figures by Country
3.6.1 Asia Pacific Alpha Synuclein Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Alpha Synuclein Sales by Country (2018-2029)
3.6.3 Asia Pacific Alpha Synuclein Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Alpha Synuclein Market Facts & Figures by Country
3.7.1 Latin America Alpha Synuclein Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Alpha Synuclein Sales by Country (2018-2029)
3.7.3 Latin America Alpha Synuclein Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Alpha Synuclein Market Facts & Figures by Country
3.8.1 Middle East and Africa Alpha Synuclein Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Alpha Synuclein Sales by Country (2018-2029)
3.8.3 Middle East and Africa Alpha Synuclein Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Alpha Synuclein Sales by Type (2018-2029)
4.1.1 Global Alpha Synuclein Sales by Type (2018-2023)
4.1.2 Global Alpha Synuclein Sales by Type (2024-2029)
4.1.3 Global Alpha Synuclein Sales Market Share by Type (2018-2029)
4.2 Global Alpha Synuclein Revenue by Type (2018-2029)
4.2.1 Global Alpha Synuclein Revenue by Type (2018-2023)
4.2.2 Global Alpha Synuclein Revenue by Type (2024-2029)
4.2.3 Global Alpha Synuclein Revenue Market Share by Type (2018-2029)
4.3 Global Alpha Synuclein Price by Type (2018-2029)
5 Segment by Application
5.1 Global Alpha Synuclein Sales by Application (2018-2029)
5.1.1 Global Alpha Synuclein Sales by Application (2018-2023)
5.1.2 Global Alpha Synuclein Sales by Application (2024-2029)
5.1.3 Global Alpha Synuclein Sales Market Share by Application (2018-2029)
5.2 Global Alpha Synuclein Revenue by Application (2018-2029)
5.2.1 Global Alpha Synuclein Revenue by Application (2018-2023)
5.2.2 Global Alpha Synuclein Revenue by Application (2024-2029)
5.2.3 Global Alpha Synuclein Revenue Market Share by Application (2018-2029)
5.3 Global Alpha Synuclein Price by Application (2018-2029)
6 Key Companies Profiled
6.1 AC Immune SA
6.1.1 AC Immune SA Corporation Information
6.1.2 AC Immune SA Description and Business Overview
6.1.3 AC Immune SA Alpha Synuclein Sales, Revenue and Gross Margin (2018-2023)
6.1.4 AC Immune SA Alpha Synuclein Product Portfolio
6.1.5 AC Immune SA Recent Developments/Updates
6.2 AFFiRiS AG
6.2.1 AFFiRiS AG Corporation Information
6.2.2 AFFiRiS AG Description and Business Overview
6.2.3 AFFiRiS AG Alpha Synuclein Sales, Revenue and Gross Margin (2018-2023)
6.2.4 AFFiRiS AG Alpha Synuclein Product Portfolio
6.2.5 AFFiRiS AG Recent Developments/Updates
6.3 BioArctic AB
6.3.1 BioArctic AB Corporation Information
6.3.2 BioArctic AB Description and Business Overview
6.3.3 BioArctic AB Alpha Synuclein Sales, Revenue and Gross Margin (2018-2023)
6.3.4 BioArctic AB Alpha Synuclein Product Portfolio
6.3.5 BioArctic AB Recent Developments/Updates
6.4 Biogen Inc
6.4.1 Biogen Inc Corporation Information
6.4.2 Biogen Inc Description and Business Overview
6.4.3 Biogen Inc Alpha Synuclein Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Biogen Inc Alpha Synuclein Product Portfolio
6.4.5 Biogen Inc Recent Developments/Updates
6.5 Evotec AG
6.5.1 Evotec AG Corporation Information
6.5.2 Evotec AG Description and Business Overview
6.5.3 Evotec AG Alpha Synuclein Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Evotec AG Alpha Synuclein Product Portfolio
6.5.5 Evotec AG Recent Developments/Updates
6.6 Genmab A/S
6.6.1 Genmab A/S Corporation Information
6.6.2 Genmab A/S Description and Business Overview
6.6.3 Genmab A/S Alpha Synuclein Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Genmab A/S Alpha Synuclein Product Portfolio
6.6.5 Genmab A/S Recent Developments/Updates
6.7 H. Lundbeck A/S
6.6.1 H. Lundbeck A/S Corporation Information
6.6.2 H. Lundbeck A/S Description and Business Overview
6.6.3 H. Lundbeck A/S Alpha Synuclein Sales, Revenue and Gross Margin (2018-2023)
6.4.4 H. Lundbeck A/S Alpha Synuclein Product Portfolio
6.7.5 H. Lundbeck A/S Recent Developments/Updates
6.8 ICB International Inc
6.8.1 ICB International Inc Corporation Information
6.8.2 ICB International Inc Description and Business Overview
6.8.3 ICB International Inc Alpha Synuclein Sales, Revenue and Gross Margin (2018-2023)
6.8.4 ICB International Inc Alpha Synuclein Product Portfolio
6.8.5 ICB International Inc Recent Developments/Updates
6.9 MedImmune LLC
6.9.1 MedImmune LLC Corporation Information
6.9.2 MedImmune LLC Description and Business Overview
6.9.3 MedImmune LLC Alpha Synuclein Sales, Revenue and Gross Margin (2018-2023)
6.9.4 MedImmune LLC Alpha Synuclein Product Portfolio
6.9.5 MedImmune LLC Recent Developments/Updates
6.10 Neuropore Therapies Inc
6.10.1 Neuropore Therapies Inc Corporation Information
6.10.2 Neuropore Therapies Inc Description and Business Overview
6.10.3 Neuropore Therapies Inc Alpha Synuclein Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Neuropore Therapies Inc Alpha Synuclein Product Portfolio
6.10.5 Neuropore Therapies Inc Recent Developments/Updates
6.11 nLife Therapeutics SL
6.11.1 nLife Therapeutics SL Corporation Information
6.11.2 nLife Therapeutics SL Alpha Synuclein Description and Business Overview
6.11.3 nLife Therapeutics SL Alpha Synuclein Sales, Revenue and Gross Margin (2018-2023)
6.11.4 nLife Therapeutics SL Alpha Synuclein Product Portfolio
6.11.5 nLife Therapeutics SL Recent Developments/Updates
6.12 Prothena Corp Plc
6.12.1 Prothena Corp Plc Corporation Information
6.12.2 Prothena Corp Plc Alpha Synuclein Description and Business Overview
6.12.3 Prothena Corp Plc Alpha Synuclein Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Prothena Corp Plc Alpha Synuclein Product Portfolio
6.12.5 Prothena Corp Plc Recent Developments/Updates
6.13 QR Pharma Inc
6.13.1 QR Pharma Inc Corporation Information
6.13.2 QR Pharma Inc Alpha Synuclein Description and Business Overview
6.13.3 QR Pharma Inc Alpha Synuclein Sales, Revenue and Gross Margin (2018-2023)
6.13.4 QR Pharma Inc Alpha Synuclein Product Portfolio
6.13.5 QR Pharma Inc Recent Developments/Updates
6.14 reMYND NV
6.14.1 reMYND NV Corporation Information
6.14.2 reMYND NV Alpha Synuclein Description and Business Overview
6.14.3 reMYND NV Alpha Synuclein Sales, Revenue and Gross Margin (2018-2023)
6.14.4 reMYND NV Alpha Synuclein Product Portfolio
6.14.5 reMYND NV Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Alpha Synuclein Industry Chain Analysis
7.2 Alpha Synuclein Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Alpha Synuclein Production Mode & Process
7.4 Alpha Synuclein Sales and Marketing
7.4.1 Alpha Synuclein Sales Channels
7.4.2 Alpha Synuclein Distributors
7.5 Alpha Synuclein Customers
8 Alpha Synuclein Market Dynamics
8.1 Alpha Synuclein Industry Trends
8.2 Alpha Synuclein Market Drivers
8.3 Alpha Synuclein Market Challenges
8.4 Alpha Synuclein Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
    Table 1. Global Alpha Synuclein Market Value Comparison by Type (2023-2029) & (US$ Million)
    Table 2. Global Alpha Synuclein Market Value Comparison by Application (2023-2029) & (US$ Million)
    Table 3. Global Alpha Synuclein Market Competitive Situation by Manufacturers in 2022
    Table 4. Global Alpha Synuclein Sales (K Pcs) of Key Manufacturers (2018-2023)
    Table 5. Global Alpha Synuclein Sales Market Share by Manufacturers (2018-2023)
    Table 6. Global Alpha Synuclein Revenue (US$ Million) by Manufacturers (2018-2023)
    Table 7. Global Alpha Synuclein Revenue Share by Manufacturers (2018-2023)
    Table 8. Global Market Alpha Synuclein Average Price (USD/Pcs) of Key Manufacturers (2018-2023)
    Table 9. Global Key Players of Alpha Synuclein, Industry Ranking, 2021 VS 2022 VS 2023
    Table 10. Global Key Manufacturers of Alpha Synuclein, Manufacturing Sites & Headquarters
    Table 11. Global Key Manufacturers of Alpha Synuclein, Product Type & Application
    Table 12. Global Key Manufacturers of Alpha Synuclein, Date of Enter into This Industry
    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Alpha Synuclein by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alpha Synuclein as of 2022)
    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 16. Global Alpha Synuclein Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 17. Global Alpha Synuclein Sales by Region (2018-2023) & (K Pcs)
    Table 18. Global Alpha Synuclein Sales Market Share by Region (2018-2023)
    Table 19. Global Alpha Synuclein Sales by Region (2024-2029) & (K Pcs)
    Table 20. Global Alpha Synuclein Sales Market Share by Region (2024-2029)
    Table 21. Global Alpha Synuclein Revenue by Region (2018-2023) & (US$ Million)
    Table 22. Global Alpha Synuclein Revenue Market Share by Region (2018-2023)
    Table 23. Global Alpha Synuclein Revenue by Region (2024-2029) & (US$ Million)
    Table 24. Global Alpha Synuclein Revenue Market Share by Region (2024-2029)
    Table 25. North America Alpha Synuclein Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 26. North America Alpha Synuclein Sales by Country (2018-2023) & (K Pcs)
    Table 27. North America Alpha Synuclein Sales by Country (2024-2029) & (K Pcs)
    Table 28. North America Alpha Synuclein Revenue by Country (2018-2023) & (US$ Million)
    Table 29. North America Alpha Synuclein Revenue by Country (2024-2029) & (US$ Million)
    Table 30. Europe Alpha Synuclein Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 31. Europe Alpha Synuclein Sales by Country (2018-2023) & (K Pcs)
    Table 32. Europe Alpha Synuclein Sales by Country (2024-2029) & (K Pcs)
    Table 33. Europe Alpha Synuclein Revenue by Country (2018-2023) & (US$ Million)
    Table 34. Europe Alpha Synuclein Revenue by Country (2024-2029) & (US$ Million)
    Table 35. Asia Pacific Alpha Synuclein Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
    Table 36. Asia Pacific Alpha Synuclein Sales by Region (2018-2023) & (K Pcs)
    Table 37. Asia Pacific Alpha Synuclein Sales by Region (2024-2029) & (K Pcs)
    Table 38. Asia Pacific Alpha Synuclein Revenue by Region (2018-2023) & (US$ Million)
    Table 39. Asia Pacific Alpha Synuclein Revenue by Region (2024-2029) & (US$ Million)
    Table 40. Latin America Alpha Synuclein Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 41. Latin America Alpha Synuclein Sales by Country (2018-2023) & (K Pcs)
    Table 42. Latin America Alpha Synuclein Sales by Country (2024-2029) & (K Pcs)
    Table 43. Latin America Alpha Synuclein Revenue by Country (2018-2023) & (US$ Million)
    Table 44. Latin America Alpha Synuclein Revenue by Country (2024-2029) & (US$ Million)
    Table 45. Middle East & Africa Alpha Synuclein Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 46. Middle East & Africa Alpha Synuclein Sales by Country (2018-2023) & (K Pcs)
    Table 47. Middle East & Africa Alpha Synuclein Sales by Country (2024-2029) & (K Pcs)
    Table 48. Middle East & Africa Alpha Synuclein Revenue by Country (2018-2023) & (US$ Million)
    Table 49. Middle East & Africa Alpha Synuclein Revenue by Country (2024-2029) & (US$ Million)
    Table 50. Global Alpha Synuclein Sales (K Pcs) by Type (2018-2023)
    Table 51. Global Alpha Synuclein Sales (K Pcs) by Type (2024-2029)
    Table 52. Global Alpha Synuclein Sales Market Share by Type (2018-2023)
    Table 53. Global Alpha Synuclein Sales Market Share by Type (2024-2029)
    Table 54. Global Alpha Synuclein Revenue (US$ Million) by Type (2018-2023)
    Table 55. Global Alpha Synuclein Revenue (US$ Million) by Type (2024-2029)
    Table 56. Global Alpha Synuclein Revenue Market Share by Type (2018-2023)
    Table 57. Global Alpha Synuclein Revenue Market Share by Type (2024-2029)
    Table 58. Global Alpha Synuclein Price (USD/Pcs) by Type (2018-2023)
    Table 59. Global Alpha Synuclein Price (USD/Pcs) by Type (2024-2029)
    Table 60. Global Alpha Synuclein Sales (K Pcs) by Application (2018-2023)
    Table 61. Global Alpha Synuclein Sales (K Pcs) by Application (2024-2029)
    Table 62. Global Alpha Synuclein Sales Market Share by Application (2018-2023)
    Table 63. Global Alpha Synuclein Sales Market Share by Application (2024-2029)
    Table 64. Global Alpha Synuclein Revenue (US$ Million) by Application (2018-2023)
    Table 65. Global Alpha Synuclein Revenue (US$ Million) by Application (2024-2029)
    Table 66. Global Alpha Synuclein Revenue Market Share by Application (2018-2023)
    Table 67. Global Alpha Synuclein Revenue Market Share by Application (2024-2029)
    Table 68. Global Alpha Synuclein Price (USD/Pcs) by Application (2018-2023)
    Table 69. Global Alpha Synuclein Price (USD/Pcs) by Application (2024-2029)
    Table 70. AC Immune SA Corporation Information
    Table 71. AC Immune SA Description and Business Overview
    Table 72. AC Immune SA Alpha Synuclein Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
    Table 73. AC Immune SA Alpha Synuclein Product
    Table 74. AC Immune SA Recent Developments/Updates
    Table 75. AFFiRiS AG Corporation Information
    Table 76. AFFiRiS AG Description and Business Overview
    Table 77. AFFiRiS AG Alpha Synuclein Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
    Table 78. AFFiRiS AG Alpha Synuclein Product
    Table 79. AFFiRiS AG Recent Developments/Updates
    Table 80. BioArctic AB Corporation Information
    Table 81. BioArctic AB Description and Business Overview
    Table 82. BioArctic AB Alpha Synuclein Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
    Table 83. BioArctic AB Alpha Synuclein Product
    Table 84. BioArctic AB Recent Developments/Updates
    Table 85. Biogen Inc Corporation Information
    Table 86. Biogen Inc Description and Business Overview
    Table 87. Biogen Inc Alpha Synuclein Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
    Table 88. Biogen Inc Alpha Synuclein Product
    Table 89. Biogen Inc Recent Developments/Updates
    Table 90. Evotec AG Corporation Information
    Table 91. Evotec AG Description and Business Overview
    Table 92. Evotec AG Alpha Synuclein Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
    Table 93. Evotec AG Alpha Synuclein Product
    Table 94. Evotec AG Recent Developments/Updates
    Table 95. Genmab A/S Corporation Information
    Table 96. Genmab A/S Description and Business Overview
    Table 97. Genmab A/S Alpha Synuclein Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
    Table 98. Genmab A/S Alpha Synuclein Product
    Table 99. Genmab A/S Recent Developments/Updates
    Table 100. H. Lundbeck A/S Corporation Information
    Table 101. H. Lundbeck A/S Description and Business Overview
    Table 102. H. Lundbeck A/S Alpha Synuclein Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
    Table 103. H. Lundbeck A/S Alpha Synuclein Product
    Table 104. H. Lundbeck A/S Recent Developments/Updates
    Table 105. ICB International Inc Corporation Information
    Table 106. ICB International Inc Description and Business Overview
    Table 107. ICB International Inc Alpha Synuclein Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
    Table 108. ICB International Inc Alpha Synuclein Product
    Table 109. ICB International Inc Recent Developments/Updates
    Table 110. MedImmune LLC Corporation Information
    Table 111. MedImmune LLC Description and Business Overview
    Table 112. MedImmune LLC Alpha Synuclein Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
    Table 113. MedImmune LLC Alpha Synuclein Product
    Table 114. MedImmune LLC Recent Developments/Updates
    Table 115. Neuropore Therapies Inc Corporation Information
    Table 116. Neuropore Therapies Inc Description and Business Overview
    Table 117. Neuropore Therapies Inc Alpha Synuclein Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
    Table 118. Neuropore Therapies Inc Alpha Synuclein Product
    Table 119. Neuropore Therapies Inc Recent Developments/Updates
    Table 120. nLife Therapeutics SL Corporation Information
    Table 121. nLife Therapeutics SL Description and Business Overview
    Table 122. nLife Therapeutics SL Alpha Synuclein Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
    Table 123. nLife Therapeutics SL Alpha Synuclein Product
    Table 124. nLife Therapeutics SL Recent Developments/Updates
    Table 125. Prothena Corp Plc Corporation Information
    Table 126. Prothena Corp Plc Description and Business Overview
    Table 127. Prothena Corp Plc Alpha Synuclein Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
    Table 128. Prothena Corp Plc Alpha Synuclein Product
    Table 129. Prothena Corp Plc Recent Developments/Updates
    Table 130. QR Pharma Inc Corporation Information
    Table 131. QR Pharma Inc Description and Business Overview
    Table 132. QR Pharma Inc Alpha Synuclein Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
    Table 133. QR Pharma Inc Alpha Synuclein Product
    Table 134. QR Pharma Inc Recent Developments/Updates
    Table 135. reMYND NV Corporation Information
    Table 136. reMYND NV Description and Business Overview
    Table 137. reMYND NV Alpha Synuclein Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
    Table 138. reMYND NV Alpha Synuclein Product
    Table 139. reMYND NV Recent Developments/Updates
    Table 140. Key Raw Materials Lists
    Table 141. Raw Materials Key Suppliers Lists
    Table 142. Alpha Synuclein Distributors List
    Table 143. Alpha Synuclein Customers List
    Table 144. Alpha Synuclein Market Trends
    Table 145. Alpha Synuclein Market Drivers
    Table 146. Alpha Synuclein Market Challenges
    Table 147. Alpha Synuclein Market Restraints
    Table 148. Research Programs/Design for This Report
    Table 149. Key Data Information from Secondary Sources
    Table 150. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Alpha Synuclein
    Figure 2. Global Alpha Synuclein Market Value Comparison by Type (2023-2029) & (US$ Million)
    Figure 3. Global Alpha Synuclein Market Share by Type in 2022 & 2029
    Figure 4. AV-1950R Product Picture
    Figure 5. AV-1947D Product Picture
    Figure 6. BAN-0805 Product Picture
    Figure 7. BIIB-054 Product Picture
    Figure 8. DPC-003 Product Picture
    Figure 9. Others Product Picture
    Figure 10. Global Alpha Synuclein Market Value Comparison by Application (2023-2029) & (US$ Million)
    Figure 11. Global Alpha Synuclein Market Share by Application in 2022 & 2029
    Figure 12. Multiple System Atrophy
    Figure 13. Neurodegenerateive Disease
    Figure 14. Lewy Body Dementia
    Figure 15. Others
    Figure 16. Global Alpha Synuclein Revenue, (US$ Million), 2018 VS 2022 VS 2029
    Figure 17. Global Alpha Synuclein Market Size (2018-2029) & (US$ Million)
    Figure 18. Global Alpha Synuclein Sales (2018-2029) & (K Pcs)
    Figure 19. Global Alpha Synuclein Average Price (USD/Pcs) & (2018-2029)
    Figure 20. Alpha Synuclein Report Years Considered
    Figure 21. Alpha Synuclein Sales Share by Manufacturers in 2022
    Figure 22. Global Alpha Synuclein Revenue Share by Manufacturers in 2022
    Figure 23. The Global 5 and 10 Largest Alpha Synuclein Players: Market Share by Revenue in 2022
    Figure 24. Alpha Synuclein Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
    Figure 25. Global Alpha Synuclein Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
    Figure 26. North America Alpha Synuclein Sales Market Share by Country (2018-2029)
    Figure 27. North America Alpha Synuclein Revenue Market Share by Country (2018-2029)
    Figure 28. U.S. Alpha Synuclein Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 29. Canada Alpha Synuclein Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 30. Europe Alpha Synuclein Sales Market Share by Country (2018-2029)
    Figure 31. Europe Alpha Synuclein Revenue Market Share by Country (2018-2029)
    Figure 32. Germany Alpha Synuclein Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 33. France Alpha Synuclein Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 34. U.K. Alpha Synuclein Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 35. Italy Alpha Synuclein Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 36. Russia Alpha Synuclein Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 37. Asia Pacific Alpha Synuclein Sales Market Share by Region (2018-2029)
    Figure 38. Asia Pacific Alpha Synuclein Revenue Market Share by Region (2018-2029)
    Figure 39. China Alpha Synuclein Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 40. Japan Alpha Synuclein Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 41. South Korea Alpha Synuclein Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 42. India Alpha Synuclein Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 43. Australia Alpha Synuclein Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 44. Taiwan Alpha Synuclein Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 45. Indonesia Alpha Synuclein Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 46. Thailand Alpha Synuclein Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 47. Malaysia Alpha Synuclein Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 48. Philippines Alpha Synuclein Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 49. Latin America Alpha Synuclein Sales Market Share by Country (2018-2029)
    Figure 50. Latin America Alpha Synuclein Revenue Market Share by Country (2018-2029)
    Figure 51. Mexico Alpha Synuclein Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 52. Brazil Alpha Synuclein Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 53. Argentina Alpha Synuclein Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 54. Middle East & Africa Alpha Synuclein Sales Market Share by Country (2018-2029)
    Figure 55. Middle East & Africa Alpha Synuclein Revenue Market Share by Country (2018-2029)
    Figure 56. Turkey Alpha Synuclein Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 57. Saudi Arabia Alpha Synuclein Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 58. UAE Alpha Synuclein Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 59. Global Sales Market Share of Alpha Synuclein by Type (2018-2029)
    Figure 60. Global Revenue Market Share of Alpha Synuclein by Type (2018-2029)
    Figure 61. Global Alpha Synuclein Price (USD/Pcs) by Type (2018-2029)
    Figure 62. Global Sales Market Share of Alpha Synuclein by Application (2018-2029)
    Figure 63. Global Revenue Market Share of Alpha Synuclein by Application (2018-2029)
    Figure 64. Global Alpha Synuclein Price (USD/Pcs) by Application (2018-2029)
    Figure 65. Alpha Synuclein Value Chain
    Figure 66. Alpha Synuclein Production Process
    Figure 67. Channels of Distribution (Direct Vs Distribution)
    Figure 68. Distributors Profiles
    Figure 69. Bottom-up and Top-down Approaches for This Report
    Figure 70. Data Triangulation
    Figure 71. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Cerebral Palsy Treatment Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-36K2790
Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global Chorea Treatment Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-22U5801
Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Hydrocephalus Shunts - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-9139
Wed Mar 27 00:00:00 UTC 2024

Add to Cart

Global Autism Diagnostic Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-29P12566
Mon Mar 25 00:00:00 UTC 2024

Add to Cart